NCT00761995View on ClinicalTrials.gov

Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Azopt

topical eye drop dosed 1 drop 3 times daily

DRUG

Cosopt

topical eye drop dosed 1 drop 2 times daily

Trial Locations (1)

560016

Alcon Laboratories, India, Bangalore

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00761995 - Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter